Literature DB >> 12860345

Correction of uterine prolapse by the vaginal route using the uterosacral ligaments: Shirodkar procedure.

Gil Dubernard1, Roman Rouzier, Bassam Haddad, Philippe Dubois, Bernard-Jean Paniel.   

Abstract

OBJECTIVE: To study long-term results of Shirodkar procedure for treatment of uterine prolapse in women wishing to retain their uterus. STUDY
DESIGN: Fifty-one patients with a symptomatic uterine prolapse who desire to preserve their uterus without further childbearing were treated between 1988 and 2000. By the vaginal route, uterosacral ligaments were separated from the uterus, shortened, transposed in front of the uterine isthmus, and fixed bilaterally under the opposite lateral surface of the cervix or of the cervical stump after amputation.
RESULTS: Median age of patients was 37 years. Median operating time was 120 min (range 60-190). One patient was re-operated four days after the initial surgery to drain a haematoma. Median follow-up was 81 months (range 11-134). Eight patients were lost of follow-up. Eleven (25.6%) patients underwent iterative surgery. The indication for re-operation was recurrence of prolapse in four patients, introital dyspareunia in three patients, cervix stenosis in two patients, urinary incontinence in one patient and pyosalpinx in one patient. Only one patient (2.3%) experienced a recurrence of the uterine prolapse.
CONCLUSION: Shirodkar procedure is safe and effective. Long-term functional results are satisfactory but associated procedures may alter patient satisfaction.

Entities:  

Mesh:

Year:  2003        PMID: 12860345     DOI: 10.1016/s0301-2115(03)00090-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  Uterine-preserving surgeries for the repair of pelvic organ prolapse: a systematic review with meta-analysis and clinical practice guidelines.

Authors:  Kate V Meriwether; Ethan M Balk; Danielle D Antosh; Cedric K Olivera; Shunaha Kim-Fine; Miles Murphy; Cara L Grimes; Ambereen Sleemi; Ruchira Singh; Alexis A Dieter; Catrina C Crisp; David D Rahn
Journal:  Int Urogynecol J       Date:  2019-02-11       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.